tiprankstipranks
Trending News
More News >
Bright Minds Biosciences (DRUG)
NASDAQ:DRUG
US Market
Advertisement

Bright Minds Biosciences (DRUG) Ownership - Who Owns Bright Minds Biosciences?

Compare
248 Followers

Bright Minds Biosciences (DRUG) Ownership Overview

30.80%1.07%44.23%3.11%20.79%
30.80% Insiders
44.23% Other Institutional Investors
3.11% ETFs
20.79% Public Companies and
Individual Investors
The ownership structure of Bright Minds Biosciences (DRUG) stock is a mix of institutional, retail, and individual investors. Approximately 48.41% of the company’s stock is owned by Institutional Investors, 30.80% is owned by Insiders, and 20.79% is owned by Public Companies and Individual Investors.
The ownership structure of Bright Minds Biosciences (DRUG) stock is a mix of institutional, retail, and individual investors. Approximately 45.30% of the company’s stock is owned by Institutional Investors, 30.80% is owned by Insiders, and 3.11% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
Apr 07, 2025
xxxxxxxxxxxxx
C$120960
Mar 07, 2025
xxxxxxxxxxxxx
$180985
Dec 11, 2024
xxxxxxxxxxxxx
C$1411795
Nov 14, 2024
xxxxxxxxxxxxx
$653408

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
1,059,331Insider14.95%72,426,460
1,004,900Insider14.18%68,705,013
420,690Institution5.94%28,762,575
206,427Institution2.91%14,113,414
157,716Institution2.23%10,783,043
57,600Insider0.81%3,938,112
49,131Institution0.69%3,359,086
37,379Institution0.53%2,555,602
28,308Institution0.40%1,935,418
20,609Insider0.29%1,409,037

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
49,131Institution0.69%3,359,086
11,604Institution0.16%793,365
5,987Institution0.08%409,331
3,337Institution0.05%228,151
2,134Institution0.03%145,902
1,390Institution0.02%95,034
896Institution0.01%61,260
435Institution<0.01%29,741
396Institution<0.01%27,075
246Institution<0.01%16,819

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
21,549Institution0.30%837,933
11,419Institution0.16%701,241
4,059Institution0.06%157,834
472Institution<0.01%29,873
352Institution<0.01%13,688

FAQ

Who Owns Bright Minds Biosciences (DRUG)?
According to the latest TipRanks data, approximately 44.23% of the company's stock is held by institutional investors, 30.80% is held by insiders, and 20.79% is held by retail investors.
    What percentage of Bright Minds Biosciences (DRUG) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 44.23% of Bright Minds Biosciences (DRUG) stock is held by institutional investors.
      What percentage of Bright Minds Biosciences (DRUG) stock is held by retail investors?
      According to the latest TipRanks data, approximately 20.79% of Bright Minds Biosciences (DRUG) stock is held by retail investors.
        Who owns the most shares of Bright Minds Biosciences (DRUG)?
        Cormorant Asset Management LP owns the most shares of Bright Minds Biosciences (DRUG).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis